| 000 | 01804 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511174845.0 | ||
| 264 | 0 | _c19930119 | |
| 008 | 199301s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00685545 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakada, M | |
| 245 | 0 | 0 |
_aThe use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1992 |
||
| 300 |
_a182-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aNeutropenia _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVindesine _xadministration & dosage |
| 700 | 1 | _aFukuoka, M | |
| 700 | 1 | _aAriyoshi, Y | |
| 700 | 1 | _aFuruse, K | |
| 700 | 1 | _aNiitani, H | |
| 700 | 1 | _aOta, K | |
| 700 | 1 | _aMotomiya, M | |
| 700 | 1 | _aHasegawa, K | |
| 700 | 1 | _aTominaga, K | |
| 700 | 1 | _aKuriyama, T | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 31 _gno. 3 _gp. 182-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00685545 _zAvailable from publisher's website |
| 999 |
_c1287976 _d1287976 |
||